Literature DB >> 16482536

Prevalence and risk factors for hepatitis C virus infection in Mongolian children: Findings from a nationwide survey.

Dambadarjaa Davaalkham1, Toshiyuki Ojima, Pagvajav Nymadawa, Ritei Uehara, Makoto Watanabe, Izumi Oki, Yosikazu Nakamura.   

Abstract

Although the hepatitis C virus (HCV) infection is one of the major causes of chronic hepatitis and hepatocellular carcinoma (HCC) in Mongolia, its prevalence among children and routes of transmission are largely unknown. The aim of the study was to determine the prevalence of anti-HCV antibodies and the possible risk factors for transmission among school children using representative national data. A nationwide cross-sectional survey among elementary school children was conducted in four main geographical regions and the metropolitan area of Mongolia, through multistage, stratified, random cluster sampling. Serum samples from 1,145 children (response rate, 93%; 592 boys and 553 girls; age range, 7-12 years), which represented nearly 2% of the second grade population in Mongolia, were tested for HCV antibodies with a third-generation immunoradiometric assay (IRMA). Positive samples were further evaluated by a third-generation immunoblot assay (RIBA). A standardized questionnaire concerning the socio-demographic characteristics and potential risk factors was used. Overall, seven subjects were confirmed to be anti-HCV seropositive, giving a prevalence of 0.6% (95% CI: 0.15-1.0%). The prevalence of anti-HCV increased with age. In the multivariate logistic regression analysis, adjusted for age, sex, and residence, the history of dental manipulation (odds ratio [OR] = 15.4; 95% CI: 1.4-164.8) and surgery (OR = 8.3; 95% CI: 1.5-45.6) were associated independently with the presence of anti-HCV. These findings suggest that contaminated equipment used in the dental and surgical manipulations probably played a predominant role in HCV transmission among Mongolian children. Strict guidelines on disinfection and sterilization procedures of medical instruments have to be introduced and should be followed to improve the control of HCV infection in Mongolia. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482536     DOI: 10.1002/jmv.20563

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Hepatitis B, C, and D Virus Infections and AFP Tumor Marker Prevalence Among the Elderly Population in Mongolia: A Nationwide Survey.

Authors:  Davaalkham Dambadarjaa; Yerkyebulan Mukhtar; Enkh-Oyun Tsogzolbaatar; Ser-Od Khuyag; Angarmurun Dayan; Nandin-Erdene Oyunbileg; Oyu-Erdene Shagdarsuren; Gunchmaa Nyam; Yosikazu Nakamura; Masaharu Takahashi; Hiroaki Okamoto
Journal:  J Prev Med Public Health       Date:  2022-05-20

2.  Administration of hepatitis B vaccine in winter as a significant predictor of the poor effectiveness of vaccination in rural Mongolia: evidence from a nationwide survey.

Authors:  Dambadarjaa Davaalkham; Toshiyuki Ojima; Steven Wiersma; Tserenkhuu Lkhagvasuren; Pagvajav Nymadawa; Ritei Uehara; Makoto Watanabe; Izumi Oki; Yosikazu Nakamura
Journal:  J Epidemiol Community Health       Date:  2007-07       Impact factor: 3.710

Review 3.  Chronic hepatitis C virus infection in children and adolescents: Epidemiology, natural history, and assessment of the safety and efficacy of combination therapy.

Authors:  Giuseppe Indolfi; Elisa Bartolini; Davide Casavola; Massimo Resti
Journal:  Adolesc Health Med Ther       Date:  2010-10-05

4.  Surveys, Serologies, and Sequences Reveal History of Iatrogenic Transmission of HIV-1.

Authors:  Simon D W Frost; Samuel K Kwofie
Journal:  J Infect Dis       Date:  2016-01-14       Impact factor: 5.226

5.  Innovative sources for funding of viral hepatitis prevention and treatment in low- and middle-income countries: a roundtable meeting report.

Authors:  David FitzSimons; Greet Hendrickx; Johannes Hallauer; Heidi Larson; Daniel Lavanchy; Ina Lodewyckx; Daniel Shouval; John Ward; Pierre Van Damme
Journal:  Hepatol Med Policy       Date:  2016-12-16

6.  Impact of the universal hepatitis B immunization program in Mongolia: achievements and challenges.

Authors:  Dambadarjaa Davaalkham; Toshiyuki Ojima; Ritei Uehara; Makoto Watanabe; Izumi Oki; Steven Wiersma; Pagvajav Nymadawa; Yosikazu Nakamura
Journal:  J Epidemiol       Date:  2007-05       Impact factor: 3.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.